PolyPeptide Group AG
SIX:PPGN.SW
31.95 (CHF) • At close September 18, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | PolyPeptide Group AG |
Symbool | PPGN.SW |
Munteenheid | CHF |
Prijs | 31.95 |
Beurswaarde | 1,053,826,563 |
Dividendpercentage | 0% |
52-weken bereik | 14.11 - 35.8 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Juan Jose Gonzalez |
Website | https://www.polypeptide.com |
An error occurred while fetching data.
Over PolyPeptide Group AG
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CHF)
Cijfers zijn in miljoenen (CHF)